Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Disclosures Heading link

The speakers, planning committee members, and reviewers who contributed to this program have no relevant financial conflicts of interest to disclose unless noted below.

  • Speaker, Dr. Chintan Patel has stock ownership with companies: Abbvie, Caladrius Biosciences Inc, Clover Health Investments Corp, Diffusion Pharmaceuticals Inc, Dynavax Technologies Corp, Gilead Sciences Inc, Glasko Smith Kline, Haleon, lmmunocellular Therapeutics, Motus GI Holdings Inc, Novabay Pharmaceuticals Inc, Novavax Inc, Ocugen Inc, Pfizer Inc, Protalix Biotherapeutics Inc, PuImatrix Inc, Quince Therapeutics Inc, Salarius Pharmaceuticals inc, Synthetic Biologics Inc, and Vaccinex Inc.
  • Speaker, Dr. Stewart Chung has stock ownership with companies Takeda and Silo Pharmaceutical.

All relevant financial relationships listed for the above speakers have been mitigated.

Speakers Heading link